← Back to directory

David E. Neal

Researcher Next ID · RN-031844

Researcher · Biochemistry, Genetics and Molecular Biology

Nuffield Orthopaedic Centre

Oxford, United Kingdom

Accepting doctoral researchersFunding unknown
Works count
1,277
Citation count
68,672
H-index
124
i10-index
580

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Prostate Cancer Treatment and Research
Prostate Cancer Diagnosis and Treatment
Bladder and Urothelial Cancer Treatments
Urinary Bladder and Prostate Research
Cancer, Lipids, and Metabolism

Publications

  • Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

    Nature Genetics · 2023 · https://doi.org/10.1038/s41588-023-01534-4

  • Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

    New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2214122

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    Nature Genetics · 2021 · https://doi.org/10.1038/s41588-020-00748-0

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Nature Genetics · 2018 · https://doi.org/10.1038/s41588-018-0142-8

  • Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

    BMJ · 2018 · https://doi.org/10.1136/bmj.j5757

  • 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

    New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1606220

  • Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

    New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1606221

  • Mutational signatures of ionizing radiation in second malignancies

    Nature Communications · 2016 · https://doi.org/10.1038/ncomms12605

  • Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

    Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1227

  • Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

    JNCI Journal of the National Cancer Institute · 2015 · https://doi.org/10.1093/jnci/djv095

  • The evolutionary history of lethal metastatic prostate cancer

    Nature · 2015 · https://doi.org/10.1038/nature14347

  • Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

    EBioMedicine · 2015 · https://doi.org/10.1016/j.ebiom.2015.07.017

  • Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

    The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)71021-6

  • Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

    Nature Genetics · 2013 · https://doi.org/10.1038/ng.2560

  • A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer

    Nature Genetics · 2012 · https://doi.org/10.1038/ng.2437

  • Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

    Nature Genetics · 2011 · https://doi.org/10.1038/ng.882

  • Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

    Nature Genetics · 2009 · https://doi.org/10.1038/ng.450

  • Multiple loci on 8q24 associated with prostate cancer susceptibility

    Nature Genetics · 2009 · https://doi.org/10.1038/ng.452

  • Multiple newly identified loci associated with prostate cancer susceptibility

    Nature Genetics · 2008 · https://doi.org/10.1038/ng.90

  • Multiple Loci With Different Cancer Specificities Within the 8q24 Gene Desert

    JNCI Journal of the National Cancer Institute · 2008 · https://doi.org/10.1093/jnci/djn190

  • Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

    Health Technology Assessment · 2003 · https://doi.org/10.3310/hta7140

  • Quality improvement report Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study Commentary: presenting unbiased information to patients can be difficult

    BMJ · 2002 · https://doi.org/10.1136/bmj.325.7367.766

  • Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.

    PubMed · 1993

Current projects

    No projects listed.